Safety and tolerability of consensus interferon-alpha [interferon alfacon-1] plus interferon gamma-1b with or without ribavirin (RBV) in the treatment of patients with chronic hepatitis C who are non-responders to PEG-IFN-a (2a or 2b) [peginterferon-alfa] plus RBV
Phase of Trial: Phase II
Latest Information Update: 29 Oct 2007
At a glance
- Drugs Interferon alfacon-1; Interferon gamma-1b; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions
- 29 Oct 2007 Status change from in progress to completed.
- 03 Oct 2005 New trial record.